… the pharmaceutical landscape by accelerating drug discovery, streamlining development timelines, … year timeline typically required for drug discovery and development. He noted … strong career opportunities across pharma, biotech, and CRO sectors. Dr. …

… show that key drug and diagnostics developers are … key development-stage biotechs. Genetic disease drug developer PYC Therapeutics … consolidate … At least two biotechs are seeking shareholder consent … Cashed-up clinical-stage biotechs are poised to go …

Antibody-drug conjugates (ADC), a fast-growing … Duality Biotherapeutics, which organised a biotech forum in Shanghai last week … to launch a novel ADC drug for a difficult-to-treat … market with a less differentiated drug for another cancer.

… billions of dollars to acquire biotechnology company Avidity Biosciences, which … a recent upswing in biotech dealmaking that’s helped … billion deal for heart drug developer The Medicines Company … technology that can deliver RNA drugs — which are largely …

… Novartis agreed to buy biotechnology company Avidity Biosciences in a … biotechnology M&A as large pharma companies buy smaller drugmakers … The New York-based biotech Tourmaline is developing a … the acquisition of US biotech Anthos Therapeutics for as …

… commit the drug developers to selling their drugs to … said. Diminished fears about drug pricing and especially interest … 520 (targeting CD70). Adverum Biotechnologies (NASDAQ: ADVM) shares slipped … trial (NCT06747858) assessing the drug’s safety, tolerability, …

… drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech … for some of its blockbuster drugs, including Entresto for heart … working on two other drugs for serious muscle diseases. … working on three experimental drug candidates aimed at treating rare …

… . I am on prescription drugs to prevent paralysis attacks. … Have you soured on the biotech industry generally? “No. Advancement … very worried about that. Biotechnology itself is a wonderful … scientists telling reporters – the biotech industry is over regulated. …

… of India's biotechnology drug regulation framework by bringing cell … ), after consultation with the Drugs Technical Advisory Board. Published … DNA (r-DNA) derived drugs” occurred shall be substituted with … DNA (r-DNA) derived drugs/; Cell or Stem Cell …

… Lilly and Company and Adverum Biotechnologies, Inc., a clinical- … for Lilly to acquire Adverum Biotechnologies, Inc., including its product … U.S. Food and Drug Administration, as well as … chief executive officer of Adverum Biotechnologies. "We share Lilly …